DALLAS, Nov. 6, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic ...
Extracorporeal cardiopulmonary resuscitation (CPR) restores perfusion and oxygenation in a patient who does not have spontaneous circulation. The evidence with regard to the effect of extracorporeal ...
Venoarterial extracorporeal membrane oxygenation (VA ECMO) for extracorporeal cardiopulmonary resuscitation (ECPR) can be used as an option to manage in-hospital and out-of-hospital refractory cardiac ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received 510(k) clearance for extracorporeal membrane oxygenation ...
WEDNESDAY, May 7, 2025 (HealthDay News) -- An artificial intelligence (AI)-driven model can significantly improve procedural safety in cardiac electrophysiology with real-time decision support, ...
BERLIN, Germany—In response to technological advances over the past several years, heart rhythm societies from around the world have released a comprehensive new expert consensus statement on catheter ...
Please provide your email address to receive an email when new articles are posted on . Several Biosense Webster AF ablation products received FDA approval for use without fluoroscopy. Use of ...
Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes
The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but ...
Findings show enhanced precision in identifying termination sites in patients with persistent atrial fibrillation. (HealthDay News) — An artificial intelligence (AI)-driven model can significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results